Radford joins Nanosonics
Thursday, 05 June, 2008
Nanosonics Ltd (ASX: NAN) has appointed a new CEO to lead the disinfection technology company's latest product roll-out.
The new CEO, David Radford, has 20 years of experience in the medical device and healthcare industries. He also has an honours degree in applied biological science from Bristol Polytechnic.
The company said Radford has extensive experience driving rapid growth in the ultrasound product market, which makes him the perfect person to oversee the company's roll-out of its new ultrasound disinfection devices.
Radford takes the helm from Nanosonics CFO Chris Grundy, who had been acting as CEO, and from Dr David Fisher, who had taken on the role of interim executive director.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
